INNOVIVA, INC. Debt Instrument, Decrease, Forgiveness
INNOVIVA, INC. (INVA) reported Debt Instrument, Decrease, Forgiveness of $16.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-02-26.
Discontinued › Notes › Debt › Debt Instrument, Increase (Decrease), Net
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2013-02-26
- INNOVIVA, INC. debt instrument, decrease, forgiveness for the quarter ending 2011-12-31 was $0.00.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for the quarter ending 2011-09-30 was $15.00K, a 7.14% increase year-over-year.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for the quarter ending 2011-06-30 was $0.00.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for the quarter ending 2011-03-31 was $1.00K.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for fiscal 2011 was $16.00K, a 100.00% increase from fiscal 2010.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for fiscal 2010 was $8.00K.
- INNOVIVA, INC. debt instrument, decrease, forgiveness for fiscal 2009 was -$13.00K.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 6 month | Debt Instrument, Decrease, Forgiveness 9 month | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $15.00K derived: sum of 2 quarters · filed 2013-02-26 | $15.00K derived: sum of 3 quarters · filed 2013-02-26 | $16.00K 10-K · filed 2013-02-26 |
| 2011-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $15.00K derived: sum of 2 quarters · filed 2012-10-31 | $16.00K 10-Q · filed 2012-10-31 | $6.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $1.00K 10-Q · filed 2012-08-01 | -$9.00K derived: sum of 3 quarters · filed 2013-02-26 | $5.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $1.00K 10-Q · filed 2012-05-02 | -$9.00K derived: sum of 2 quarters · filed 2013-02-26 | $5.00K derived: sum of 3 quarters · filed 2013-02-26 | |
| 2010-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $4.00K derived: sum of 2 quarters · filed 2013-02-26 | $8.00K 10-K · filed 2013-02-26 | |
| 2010-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $18.00K 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $4.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | -$13.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |